OKYONasdaqBiological Products, (No Diagnostic Substances)
OKYO Pharma Ltd
Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jul 20, 2026
$1.40−0.01 (-0.71%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.84 (−37.50%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Mar 31, 2026
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- EPS, diluted
- -$0.24
- Free cash flow
- -$5.94M
Eight years at a glance
Fiscal years 2019 to 2026, USD
EPS, diluted
-$0.24
Free cash flow
-$5.94M
Reported period